Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas

The Idylla NRAS Mutation Test, performed on the Biocartis Idylla system, is an in vitro diagnostic tool for the qualitative assessment of 18 NRAS mutations in codons 12, 13, 59, 61, 117, and 146. Low-grade serous ovarian cancer (LGSC) represents less than 10% of all serous ovarian carcinomas. LGSCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadlecki, Pawel, Grzanka, Dariusz, Grabiec, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845515/
https://www.ncbi.nlm.nih.gov/pubmed/29682098
http://dx.doi.org/10.1155/2018/1497879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845515/
https://www.ncbi.nlm.nih.gov/pubmed/29682098
http://dx.doi.org/10.1155/2018/1497879

Ejemplares similares